858-692-3573 info@denovicontx.com

On September 14, 2021, Denovicon Therapeutics Founder & CEO, Scott Bembenek, will present on Denovicon’s ‘AI–Molecular Modeling Platform for Enhanced Small-Molecule Drug Discovery’ at the Biovia User Group Meeting 2021.